{
  "title": "Rx Savings' Rea on Mylan Under Scrutiny for EpiPen Price(Audio)",
  "itunes:title": "Rx Savings' Rea on Mylan Under Scrutiny for EpiPen Price(Audio)",
  "description": "<p>(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.\n\nGUEST:\nMichael Rea, CEO of Rx Savings Solutions, to discuss Mylan's EpiPen price hike, currently under scrutiny.</p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "content:encoded": "<p>(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.\n\nGUEST:\nMichael Rea, CEO of Rx Savings Solutions, to discuss Mylan's EpiPen price hike, currently under scrutiny.</p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "itunes:summary": "Rx Savingsâ€™ Rea on Mylan Under Scrutiny for EpiPen Price(Audio)",
  "itunes:episodeType": "full",
  "itunes:author": "Bloomberg",
  "itunes:image": "",
  "media:content": [
    {
      "media:player": ""
    },
    ""
  ],
  "guid": "https://assets.bwbx.io/av/users/iqjWHBFdfxIU/vtkyqAWHux1M/v2.mp3",
  "omny:clipId": "d60d8f18-f36e-4917-92fd-ae3c008e7067",
  "pubDate": "Wed, 24 Aug 2016 18:43:20 +0000",
  "itunes:duration": 480,
  "enclosure": "",
  "link": "https://omny.fm/shows/the-tape/rx-savings-rea-on-mylan-under-scrutiny-for-epipen"
}